Gain Therapeutics Inc (GANX)

Finanzdaten der Gain Therapeutics Inc-Aktie (GANX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	12.55%4.68	5.35	4.47	4.79	5.09
Research and Development	22.62%2.14	2.76	2.35	2.85	2.76
Operating Income/Loss	12.55%-4.68	-5.35	-4.47	-4.79	-5.09
Income/Loss From Continuing Operations Before Tax	15.74%-4.57	-5.43	-4.47	-4.74	-5.67
Income Tax Expense/Benefit	43.15%0.10	0.18	0.07	0.55	0.14
	16.64%-4.68	-5.61	-4.54	-5.28	-5.81
Attributable To Parent	16.64%-4.68	-5.61	-4.54	-5.28	-5.81
Basic Average Shares	1.54%42.88	42.23	-	35.00	30.34
Diluted Average Shares	1.54%42.88	42.23	-	35.00	30.34
Basic Earnings Per Share	15.38%-0.11	-0.13	-	-0.15	-0.19
Diluted Earnings Per Share	15.38%-0.11	-0.13	-	-0.15	-0.19